Updates on three of six ongoing Phase III Ramucirumab trials to be presented
14 May 2012 | By Eli Lilly and Company
Eli Lilly and Company will present data from several molecules...
List view / Grid view
News
Bristol-Myers Squibb and Tsinghua University enter strategic partnership
14 May 2012 | By Bristol-Myers Squibb
Under the agreement, Bristol-Myers Squibb will fund research efforts at Tsinghua University’s School of Life Sciences...
Lilly Oncology to highlight final results for Phase III study in most common form of lung cancer
14 May 2012 | By Eli Lilly and Company
Eli Lilly and Company will present data from more than 25 studies...
Pfizer to present new data in advanced kidney, lung and Hhmatologic cancers
14 May 2012 | By Pfizer
New data will be presented on targeted cancer treatments from the Pfizer Oncology portfolio across three key therapeutic categories...
Statistically significant clinical phase III results of Lu AA21004
14 May 2012 | By H. Lundbeck A/S
H. Lundbeck A/S announced positive top-line results from three recently completed phase III clinical studies of Lu AA21004...
Bristol-Myers Squibb to present new data on ORENCIA®
14 May 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced that the company will present 18 abstracts on ORENCIA®...
New AVONEX® dosing innovations for people with Multiple Sclerosis now available in US
14 May 2012 | By Biogen Idec
Two new dosing innovations designed to help patients receiving once-a-week AVONEX...
Academia-pharma collaboration attracts £14.4million funding in the UK to accelerate drug discovery
14 May 2012 | By University of Dundee
The consortium includes six companies & will provide core support of £14.4 million...
B&W Tek announces a quantum leap in the evolution of miniature CCD spectrometer technology
14 May 2012 | By B&W Tek, Inc.
B&W Tek, Inc., is proud to introduce the future of miniature spectrometers...
Catalent expert gives working group update at extractables and leachables conference in Baltimore, USA
11 May 2012 | By Catalent Pharma Solutions
Thomas Feinberg, will deliver an update on the PODP working group...
FDA Advisory Committee supports approval of Gilead’s once-daily Quad single tablet regimen for HIV
11 May 2012 | By Gilead Sciences
Final FDA decision on the Quad anticipated late summer...
Stiefel receives US FDA approval of Fabior™ Foam, 0.1%
11 May 2012 | By GlaxoSmithKline
The FDA has approved the New Drug Application for Fabior (tazarotene) Foam...
Cisbio Bioassays adds three cellular kinase assays to its kinase screening platform
10 May 2012 | By Ballou PR
Company combines expertise in assay design with its powerful HTRF® technology...
New data among 200 Lucentis® abstracts at ARVO
10 May 2012 | By Novartis
Research on Lucentis® is highlighted in more than 200 abstracts this week at the 2012 ARVO annual meeting....
Webcast of Pfizer discussion at healthcare conference
10 May 2012 | By Pfizer
Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with David Simmons...
